Stock Track | Moderna Soars 5% in Pre-Market on Positive Momentum and CEO's Stock Purchase

Stock Track

Mar 05

Moderna, Inc. (MRNA) stock soared 5% in pre-market trading on Wednesday, building on the positive momentum from the previous session and boosted by news of the CEO's significant stock purchase.

On Tuesday, Moderna's shares surged 5.04% in after-hours trading, defying expectations after an analyst at Redburn Atlantic lowered its price target on the pharmaceutical company's stock. Despite the downward revision, which suggested potentially weaker expectations for Moderna's future performance or valuation, investors seemed undeterred and pushed the stock higher.

Further fueling the pre-market rally was the revelation that Moderna's CEO, Stephane Bancel, had made open market purchases totaling approximately $5 million, acquiring 160,314 shares of the company's common stock. This significant investment by the top executive reflects Bancel's continued confidence in Moderna's future prospects as the company continues to innovate within the life sciences sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1157377781"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157377781\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157377781?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-05 17:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157377781","market":"us","top_or_hot":-1,"title":"Stock Track | Moderna Soars 5% in Pre-Market on Positive Momentum and CEO's Stock Purchase","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) stock soared 5% in pre-market trading on Wednesday, building on the positive momentum from the previous session and boosted by news of the CEO's significant stock purchase.</p>\n\n<p>On Tuesday, Moderna's shares surged 5.04% in after-hours trading, defying expectations after an analyst at Redburn Atlantic lowered its price target on the pharmaceutical company's stock. Despite the downward revision, which suggested potentially weaker expectations for Moderna's future performance or valuation, investors seemed undeterred and pushed the stock higher.</p>\n\n<p>Further fueling the pre-market rally was the revelation that Moderna's CEO, Stephane Bancel, had made open market purchases totaling approximately $5 million, acquiring 160,314 shares of the company's common stock. This significant investment by the top executive reflects Bancel's continued confidence in Moderna's future prospects as the company continues to innovate within the life sciences sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 5% in Pre-Market on Positive Momentum and CEO's Stock Purchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 5% in Pre-Market on Positive Momentum and CEO's Stock Purchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-05 17:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) stock soared 5% in pre-market trading on Wednesday, building on the positive momentum from the previous session and boosted by news of the CEO's significant stock purchase.</p>\n\n<p>On Tuesday, Moderna's shares surged 5.04% in after-hours trading, defying expectations after an analyst at Redburn Atlantic lowered its price target on the pharmaceutical company's stock. Despite the downward revision, which suggested potentially weaker expectations for Moderna's future performance or valuation, investors seemed undeterred and pushed the stock higher.</p>\n\n<p>Further fueling the pre-market rally was the revelation that Moderna's CEO, Stephane Bancel, had made open market purchases totaling approximately $5 million, acquiring 160,314 shares of the company's common stock. This significant investment by the top executive reflects Bancel's continued confidence in Moderna's future prospects as the company continues to innovate within the life sciences sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1157377781","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157377781","pubTimestamp":1741168354,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc.  stock soared 5% in pre-market trading on Wednesday, building on the positive momentum from the previous session and boosted by news of the CEO's significant stock purchase.On Tuesday, Moderna's shares surged 5.04% in after-hours trading, defying expectations after an analyst at Redburn Atlantic lowered its price target on the pharmaceutical company's stock. Despite the downward revision, which suggested potentially weaker expectations for Moderna's future performance or valuation,","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"由于积极的势头和首席执行官的股票购买，Moderna在盘前飙升5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) stock soared 5% in pre-market trading on Wednesday, building on the positive momentum from the previous session and boosted by news of the CEO's significant stock purchase.\nOn Tuesday, Moderna's shares surged 5.04% in after-hours trading, defying expectations after an analyst at Redburn Atlantic lowered its price target on the pharmaceutical company's stock. Despite the downward revision, which suggested potentially weaker expectations for Moderna's future performance or valuation, investors seemed undeterred and pushed the stock higher.\nFurther fueling the pre-market rally was the revelation that Moderna's CEO, Stephane Bancel, had made open market purchases totaling approximately $5 million, acquiring 160,314 shares of the company's common stock. This significant investment by the top executive reflects Bancel's continued confidence in Moderna's future prospects as the company continues to innovate within the life sciences sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}